Dr Lal Pathlabs Ltd vs Thyrocare Technologies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 03, 2026

Key Highlights

The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 1329 as of 02 Apr 15:30 . The P/E Ratio of Dr Lal Pathlabs Ltd changed from 77.4 on March 2021 to 42.5 on March 2025 . This represents a CAGR of -11.30% over 5 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 42.2 on March 2021 to 39.4 on March 2025 . This represents a CAGR of -1.36% over 5 years The Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 22565 crore on March 2021 to ₹ 20714 crore on March 2025 . This represents a CAGR of -1.70% over 5 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 4774 crore on March 2021 to ₹ 3604 crore on March 2025 . This represents a CAGR of -5.47% over 5 years The revenue of Dr Lal Pathlabs Ltd for the Dec '25 is ₹ 684.2 crore as compare to the Sep '25 revenue of ₹ 755.4 crore. This represent the decline of -9.43% The revenue of Thyrocare Technologies Ltd for the Dec '25 is ₹ 200.79 crore as compare to the Sep '25 revenue of ₹ 219.86 crore. This represent the decline of -8.67% The ebitda of Dr Lal Pathlabs Ltd for the Dec '25 is ₹ 173.6 crore as compare to the Sep '25 ebitda of ₹ 248.9 crore. This represent the decline of -30.25% The ebitda of Thyrocare Technologies Ltd for the Dec '25 is ₹ 56.93 crore as compare to the Sep '25 ebitda of ₹ 74.68 crore. This represent the decline of -23.77% The net profit of Dr Lal Pathlabs Ltd changed from ₹ 107.8 crore to ₹ 91.4 crore over 7 quarters. This represents a CAGR of -9.00% The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 28.05 crore over 7 quarters. This represents a CAGR of 9.48% The Dividend Payout of Dr Lal Pathlabs Ltd changed from 59.51 % on March 2021 to 40.34 % on March 2025 . This represents a CAGR of -7.48% over 5 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 116.18 % on March 2025 . This represents a CAGR of 1.03% over 5 years .

About Dr Lal Pathlabs Ltd

Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.

FAQs for the comparison of Dr Lal Pathlabs Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Dr Lal Pathlabs Ltd or Thyrocare Technologies Ltd?

Market cap of Dr Lal Pathlabs Ltd is 22,273 Cr while Market cap of Thyrocare Technologies Ltd is 5,827 Cr

What are the key factors driving the stock performance of Dr Lal Pathlabs Ltd and Thyrocare Technologies Ltd?

The stock performance of Dr Lal Pathlabs Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lal Pathlabs Ltd and Thyrocare Technologies Ltd?

As of April 3, 2026, the Dr Lal Pathlabs Ltd stock price is INR ₹1329.3. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹366.15.

How do dividend payouts of Dr Lal Pathlabs Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Dr Lal Pathlabs Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.